
![]() |
|||||||||||||
WJPR Citation Report
|
| All | Since 2021 | |
| Citation | 9186 | 4781 |
| h-index | 32 | 25 |
| i10-index | 256 | 108 |
EFFICIENT SCALABLE APPROACH FOR CLOPIDOGREL BISULFATE THROUGH PREFERENTIAL CRYSTALLIZATION OF(±)-2-(2-CHLOROPHENYL)-(6,7-DIHYDRO-4HTHIENO[ 3,2,C]PYRIDINE-5-YL-ACETAMIDE.
M. M. V. Ramana* and Rajesh K. Rao.
Abstract The present work deals with the efficient synthesis of Clopidogrel Bisulfate (Generic name : Plavix by Sanofi) through resolution of an important precursor (±) -2-(2-chlorophenyl)-(6,7-dihydro-4Hthieno[ 3,2,c]pyridine-5-yl-acetamide by preferential crystallization. This compound was synthesized in its racemic form as per the known process and was resolved by preferential crystallization. These efforts led to a successful isolation of enantiomerically pure isomers of (±)-2- (2-chlorophenyl)-(6,7-dihydro-4H-thieno[3,2,c]pyridine-5-ylacetamide. Keywords: Clopidogrel Bisulfate, Preferential Crystallization, Racemic compound, Conglomerate, Racemization. [Full Text Article] [Download Certificate] |
